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a b s t r a c t
Connexin43 (Cx43) is critical for maintaining electrical conduction across atrial muscle. During progres-
sive ageing atrial conduction slows associating with increasing susceptibility to arrhythmias. Changes in
Cx43 protein expression, or its phosphorylation status, can instigate changes in the conduction of the
cardiac action potential. This study investigated whether increased levels of activated c-jun N-terminal
kinase (JNK) is responsible for the decline of Cx43 during ageing. Right atria from guinea pigs aged
between 1 day and 38 months of age were examined. The area of the intercalated disc increased with age
concurrent with a 75% decline in C43 protein expression. An age-dependent increase in activated-JNK
correlated with a rise in phosphorylated Cx43, but also slowing of action potential conduction velocity
across the atria from 0.38±0.01m/s at 1 month of age to 0.30±0.01m/s at 38 months. The JNK activator
anisomycin increased activated JNK in myocytes and reduced Cx43 protein expression simulating age-
ing. The JNK inhibitor SP600125, was found to eradicate almost all trace of Cx43 protein. We conclude
that in vivo activation of JNK increases with age leading to the loss of Cx43 protein resulting in impaired
conduction and contributing to the increasing risk of atrial arrhythmias with advancing age.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Approximately 20% of the population are over 65 years of
age, and by 2050 this is predicted to increase to over a quarter
of the Western population (Cracknell, 2010). Ageing is consid-
ered to be the highest risk factor for cardiac arrhythmias. Ageing
associates with progressive remodelling of heart muscle and a pro-
gressive increase in the incidence of conduction abnormalities,
uncoordinated contraction and diminished myocardial function. In
advanced age this is particularly evident within the right atria and
sinoatrial node with an age-associated increase in sick sinus syn-
drome and atrial ﬁbrillation (Centurión et al., 2005; Jones et al.,
2004; Roberts-Thomson et al., 2009).
Cardiac myocytes are linked at their intercalated discs. These
essentially consist of ‘mechanical junctions’ to bond cells together,
and ‘gap junctions’ composed from a family of proteins known as
connexins (Cx) responsible for intercellular communication and
propagation of the actionpotential (for a fuller review seeNoorman
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et al., 2009). Cx43 is the most abundantly expressed isoform in
heartmusclewithadditional isoformssuchasCx40andCx45occur-
ring at comparatively low levels. Thus, Cx43 predominately forms
cardiac gap junctions and its expression is critical for maintaining
cardiac conduction throughout the heart, with the notable excep-
tions being within the His-Purkinje conducting system, sinoatrial
and atrioventricular nodes (Jones et al., 2004; Nikolski et al., 2003).
Evenmoderate changes in gap junctional conductance directly cor-
relate with changes in cardiac conductance velocity highlighting
their key role in ensuring normal conduction in the heart (Dhillon
et al., 2014). Depletion of Cx43 has been shown to increase the risk
of arrhythmias, anda similar changeduringprogressive ageingmay
contribute to the increasing risk of arrhythmia susceptibility in old
age (Danik et al., 2004).
The activation of stress-associated signalling within the heart
progressively increases during ageing with a number of intracel-
lular pathways in cardiac myocytes potentially evoked such as
protein kinase A, protein kinase C and the intracellular signalling
family of mitogen activated protein kinase (MAPKs) including p38,
p42/44 and c-jun N-terminal kinase (JNK) (Powers et al., 2004;
Baines and Molkentin, 2005). These pathways have been impli-
cated in the regulation of cardiac conduction during episodes of
http://dx.doi.org/10.1016/j.mad.2015.05.001
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acute and chronic stress by phosphorylation of the Cx43 protein at
the C-terminus (Polontchouk et al., 2002; Remo et al., 2011).
Phosphorylation of Cx43 is complex in terms of regulation and
effect. Basal phosphorylation of Cx43 in the heart ensures proper
gap junction assembly and targeting to the intercalated disc with
de-phosphorylation in instances such as ischemia leading to gap
junction disruption (Beardslee et al., 2000). Phosphorylation effects
however are complex. Enhanced phosphorylation has also been
shown to have the potential to alter channel gating reducing con-
ductance, alter selectivity, and lead to down-regulation of Cx43
expression (for review see Solan and Lampe, 2009).
The stimulation of acutely cultured single cardiac myocytes
and HL1 cells in vitro with acute stress has been demonstrated
to provoke increased levels of activated-JNK (phosphorylated JNK
isoform) with a reduction in both Cx43 mRNA and protein levels,
(Petrich et al., 2002; Ogawa et al., 2004; Yan et al., 2013). In contrast
though other studies also using acute stress simulation in culture
to provoke activated-JNK have shown enhanced Cx43 expression
(Shyu et al., 2004; Salameh et al., 2009). Thus, the manipulation
of JNK and the ensuing effect on Cx43 protein expression within
myocytes remains controversial.
Studies of transgenic mice in vivo using the cre-LoxP-mediated
system to express MKK7D (a speciﬁc activator of JNK under the
control of the murine -MHC promoter) demonstrated that car-
diac speciﬁc over-expression of activated-JNK resulted in a 90%
reduction of Cx43 protein expression compared with their con-
trol littermates (Petrich et al., 2004). This was accompanied by the
functional affect of a 40% reduction in action potential conduction
velocity and sudden death of the transgenic mice at 6–8 weeks
highlighting the potential arrhythmogenic consequences. Further-
more, using cardiac myocytes from MKK7D over-expressing mice
the activity of JNK was inhibited in vitro and shown to attenuate
Cx43 protein expression (Petrich et al., 2002). Thus, the transgenic
over-expression mouse model illustrates JNK acts as an important
mediator in the regulation of Cx43 expression. This is further sup-
ported by the recent ﬁnding that in rabbits activation of JNK with
anisomycin lead to a 34% decline in Cx43 associating with a 50%
increase in activated JNK within the left atria. This was accompa-
nied by an increased susceptibility to atrial arrhythmias (Yan et al.,
2013).
Cx43 protein has previously been identiﬁed as a molecular
correlate inversely linked to susceptibility of atrial arrhythmias
(Kostin et al., 2002). Atrial arrhythmias, in particular atrial ﬁbril-
lation, show increasing prevalence with age and are present at a
high incidence within the elderly population (Kostin et al., 2002;
Brembilla-Perrot, 2003). Previous studies illustrate the relationship
of theprotein levelsof activated-JNKtoCx43, alongwithCx43phos-
phorylation status, indicating their potential signiﬁcance in the
mechanistic underpinnings of a higher risk for atrial arrhythmias in
old age. Therefore our hypothesis was that progressive activation
of JNK signalling and subsequent modiﬁcation of Cx43 contributes
to the “aged-heart” phenotype; a phenotype predisposed to atrial
arrhythmias.
2. Materials and methods
2.1. Animal model
Healthy female tricolor guinea pigswere obtained at 1 day (0.03
month), 1 month, 18 months, 26 months and 38 months of age
(n=5 per age group). This age range covers the previously deter-
mined life expectancy of this in-bred guinea pig strain (Jones et al.,
2004). All animal procedures were performed in accordance with
the United Kingdom Animals (scientiﬁc procedures) Act 1986 and
reviewed by the University of Hull and Leeds Biomedical Sciences
ethics committees. Animals were humanely sacriﬁced by intra-
venous administration of an overdose of pentobarbital followed by
removal of the heart and isolation of the right atrium.
2.2. Extracellular electrode recording
The intact right atriawas pinned endocardial surface uppermost
in bicarbonate buffered Tyrode’s solution, maintained at 37 ◦C, and
continued to generate spontaneous impulses (Jones et al., 2004).
Using two extracellular modiﬁed bipolar electrodes, one as a sta-
tionary reference electrode and the second as a moving electrode,
the local action potential activation time across the muscle was
measuredaspreviouslydescribed (Yamamotoet al., 1998). For each
animal examined, action potential conduction was determined in
the main direction of propagation in the atrial muscle – perpendic-
ular to the crista terminalis.
2.3. Immunoﬂuorescence
Single cardiac myocytes were isolated from right atrial tissue
by enzymatic digestion (Lancaster et al., 2004). Cells or 10m
frozen sections were subjected to immunolabelling as previously
described (Jones et al., 2002). Details of the primary antibodies
utilised are listed in Table 1. FITC-conjugated anti-rabbit or anti-
mouse antibodies, as appropriate for the primary antibody (Dako,
Denmark)were used to ﬂuorescently tag the primary antibody. Fol-
lowing immunolabelling, myocytes were incubated for 2h with
wheat germ agglutinin (WGA) conjugated to rhodamine, a lectin
that binds to N-acetylglucosamine within membranes (Vector,
Burlingame, USA) to permit visualisation of membrane morphol-
ogy.
To prevent photo-bleaching, myocytes were mounted in vec-
torshield (Vector, USA) and all slides were stored in the dark at
4 ◦C prior to examination by laser scanning confocal microscopy
(Zeiss, Hertfordshire, UK). All ﬂuorescent images were individually
collected for each optical slice, using the same microscope and set-
tings for the lasers and detector, from superimposing 6–10 optical
slices taken at ≤1m intervals at each wavelength. Images of each
intercalated disc were analysed by measuring their axes and area
using the confocal software (LSM, Zeiss). Analysis of images such
as density of label were performed using ImageJ v2.11x (NIH, USA).
Table 1
The antibodies used in this study with concentrations used and their source companies.
Antibody Source company Host Immunoﬂuorescence W-blot
g/ml g/ml
Cx40 Chemicon, Hampshire, UK Rabbit 20 10
Cx45 Chemicon, Hampshire, UK Mouse 20 10
Total endogenous Cx43 Cell signalling Tech., Hertfordshire, UK Rabbit 1 0.1
Phosphorylated Cx43 Cell signalling Tech., Hertfordshire, UK Rabbit – 1
Non-phosphorylated JNK Cell signalling Tech., Hertfordshire, UK Rabbit – 1
Phosphorylated JNK Cell signalling Tech., Hertfordshire, UK Rabbit – 1
Desmin Dako, Denmark Mouse – 6
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2.4. Western blot
Tissue was snap-frozen and processed for analysis. Samples
(50g total protein/lane) were separated by electrophoresis under
reducing conditions by 10% SDS-PAGE, followed by transfer to a
nitrocellulose membrane (Jones et al., 2004). The membrane was
immersed and agitated in superblock TBS buffer (Pierce biotech-
nology, UK) for 40min, then rinsed in TBS. Membranes were
incubated overnight with appropriate primary antibodies (see
Table 1) at 4 ◦C. The membrane was washed in Tween20 TBS, incu-
bated for one hour with anti-rabbit or anti-mouse IgG conjugated
to horseradish peroxide (HRP) (Dako, Germany), and washed in
TBS. Themembraneboundprotein-antibody complexwasdetected
using SuperSignal West Pico chemiluminescent substrate and CL-
XPosure ﬁlm (Pierce, Thermo Scientiﬁc, UK), bands were analysed
using ImageJ. Total endogenous Cx43 protein was calculated using
a commercial control of known total Cx43 protein content (Chemi-
con, UK), then expressed per g total protein (g total Cx43/g
total protein). In addition to the protein of interest, desmin protein
levels were assessed to ensure equal protein loading of all sam-
ples determined by the uniform-density of desmin bands at the
molecular weight of 53kDa.
2.5. Direct inhibition and activation of JNK in vitro
Single cardiacmyocytes isolated fromadult animals (n=5)were
placed on cover-slips and either pre-exposed for 30min to the
JNK inhibitor SP600125 (30M anthra[1,9-cd]pyrazol-6(2H)-one
in the carrier ≤0.1% DMSO) or the JNK activator anisomycin at
10ug/ml for 90min (Bennett et al., 2001;Ogawaet al., 2004; Petrich
et al., 2002). Following exposure myocytes were either frozen for
western blot analysis or plated on polysine slides and immedi-
ately ﬁxed using 4% para-formaldehyde for immunoﬂuorescence.
Myocytes were also exposed to 0.1% DMSO alone to conﬁrm DMSO
was a carrier only with no other effects.
2.6. Statistical analysis
Data are expressed as means± SEM and statistical differences
assessed by ANOVA with Holm-Sidak post-hoc comparisons or
Student’s t-test as appropriate. Differences were regarded as sig-
niﬁcant if p<0.05. Correlations were determined using linear
regression or Pearson correlation.
3. Results
3.1. Analysis of total endogenous connexin in right atrial muscle
Right atrial muscle from guinea pigs of 0.03 month (1 day) to 38
months of age (n=5 per age group) was analysed by western blot
for changes in total endogenous protein; Cx40 (bands at 40kDa),
Cx43 (doublet bands consisting of two isoforms; phosphorylated
at 43kDa and non-phosphorylated at 41kDa) and Cx45 (bands at
45kDa) (Fig. 1A). Equal protein loading was conﬁrmed by uniform
density bands of desmin protein at 53kDa (Fig. 1A). The exam-
ple membrane image illustrates the decrease in total endogenous
Cx43 protein expression with increasing animal age. In contrast,
Cx40 and Cx45 expression remain the same across the age range
(Fig. 1A). Progressive ageing signiﬁcantly reduced total endogenous
Cx43 protein in the right atria to only 24±2% of that identiﬁed
in the neonate by 38 months of age. Total Cx43 protein declined
from 0.40±0.05g/g at 0.03 months to 0.31±0.05g/g at 1
month, signiﬁcantly dropping to 0.12±0.02g/g at 18 months
and then was further reduced to 0.09±0.03g/g at 38 months of
age (Fig. 1B; ANOVA, p<0.001).
Fig. 1. Endogenous connexin expression in right atrialmuscle. (A) Illustrativemem-
branes from western blotting are shown for the connexin proteins: Cx45 (single
band at 45kDa), Cx43 doublet (band at 43kDa is phosphorylated Cx43, the band
at 41kDa is non-phosphorylated Cx43) and Cx40 (single band at 40kDa). Equal
protein-loading was conﬁrmed by desmin labelling (53kDa). (B) Total endogenous
Cx43 protein (g) per total protein (g) signiﬁcantly declined with ageing (n=5;
ANOVA p<0.001).
3.2. Dimensions of the intercalated disc increase with age
The cell width, intercalated disc major and minor axes mea-
surements, and intercalated disc area was recorded from single
isolated myocytes, obtained from the right atrial muscle for each
age group (n=30 myocytes per group). The width of myocytes
signiﬁcantly increased with ageing from 12.19±0.9m at 0.03
month to 21.81±1.3m at 38 months (Fig. 2A; ANOVA, p<0.001).
This cellular hypertrophy appears to be a normal developmental
response, with no signiﬁcant alteration in myocyte width occur-
ringbetween18and38monthsof age (17.92±1.5mat18months
comparedwith21.81±1.3mat38months). The lackof signiﬁcant
additional hypertrophy with advancing age has previously been
demonstrated for this model, as the heart weight does not change
between the 18 month to 38 month old animal and the heart-to-
body weight ratio remains constant across all ages studied (Jones
et al., 2004).
The area of intercalated disc labelled positive for total endoge-
nous Cx43 protein was deﬁned by the area within the perimeter
Cx43 signal. When the intercalated disc was examined it was
found that both axes signiﬁcantly increased; the major axis from
7.79±0.36mat 1month to 12.28±0.47mat 38months and the
minor axis from 5.23±0.25m at 1 month to 8.79±0.35m at 38
Table 2
The size of the intercalated disc with age.
Age of
animal
Major axis of the
intercalated disc
Minor axis of the
intercalated disc
(months) (m) (m)
1 7.79 ± 0.36 5.23 ± 0.25
18 10.56 ± 0.38 7.77 ± 0.27
26 12.10 ± 0.42 8.43 ± 0.19
38 12.28 ± 0.47 8.79 ± 0.35
The maximal distance across the intercalated discs was recorded as the major axis,
and the minimal distance recorded as the minor axis (n=30 for each age group;
ANOVA p<0.001).
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Fig. 3. Example projection confocal images of intercalated discs with Cx43 labelled from animals of 1 month and 38 months of age (A). For the position indicated by the
dashed line that bisects each disc image (A) an example intensity proﬁle of Cx43 distribution across the intercalated disc from animals at (B) 1 month and (C) 38 months of
age is shown.
Fig. 2. Dimensions of the intercalated disc. Myocyte width (A) and intercalated disc
area (B) signiﬁcantly increasedbetween age groups (n=30;ANOVAp<0.001). Inten-
sity of total endogenous Cx43 protein from each intercalated disc expressed as a
percentage of the total disc area (C) was found to decline with age (n=50; ANOVA
p<0.0001; linear regression, y=−0.94x+55.4).
months (Table 2; ANOVA p<0.001). The average individual inter-
calated disc area signiﬁcantly increased over the animal’s lifespan
from33.0±2.8m2 at 1month to 83.0±6.3m2 at 38months sig-
niﬁcantly correlating with progressive ageing (Fig. 2B; n=30 per
age group; ANOVA p<0.001; linear regression, y=1.423x+36.2;
R2 =0.91).
3.3. Intercalated disc total endogenous Cx43 labelling reduces
with age
The area of intercalated disc labelled positive for total endoge-
nous Cx43 protein, measured as the total intensity of Cx43
immunoﬂuorescent signal, was expressed as a percentage of the
total area of the intercalated disc (as deﬁned by the area within
the perimeter Cx43 signal). At 1 month of age 52.8±2% of the
intercalated disc labelled positive for Cx43 protein decreasing to
41.3±1% at 18 months and 32.0±1% at 26 months. By 38 months
of age, the area showing expression of Cx43 protein was 18.0±1
% of the total disc area. Overall, across the age range studied total
Cx43 at the atrial myocyte intercalated disc signiﬁcantly declined
to 34% of the original content, a process which signiﬁcantly corre-
lated with age (Fig. 2C; n=50; ANOVA p<0.001; linear regression,
y=−0.94x+55.4; R2 =0.96).
3.4. Remodelling of total Cx43 at the intercalated disc occurs with
age
The area of the intercalated disc increases with age, but in con-
trast the amount of total endogenous Cx43 protein expressed at
the disc reduced with increased age, therefore spatial re-modelling
of the distribution of the remaining Cx43 protein occurs. Inten-
sity proﬁles of ﬂuorescently-labelled endogenous Cx43 across each
intercalated disc were measured. In Fig. 3A, an illustrative dashed
line bisects the representative images of an intercalated disc for
atrial myocytes obtained from animals at the ages 1 month and 38
months. The intensity proﬁle of the representative intercalated disc
from the 1 month old animal illustrates that many Cx43 ‘hot spots’
were present across the entire disc, demonstrated by the multiple
peak proﬁle (repeated observation n=40 intercalated discs for 1
month; Fig. 2B). The intensity proﬁle of the representative inter-
calated disc from the 38 month animal showed that labelled Cx43
protein was present at the outer rim only (repeated observation
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Fig. 4. Conduction velocity in right atrialmuscle of animals from1day to 38months
of age. Endocardial action potential conduction velocity was measured perpendic-
ular to the crista terminalis (CT) as denoted by the dotted arrow in panel A. The
conduction velocity was increased at 1 month compared with the neonate but con-
duction declined over the remaining ages until 38 months (B) (n=5 per age group;
ANOVA p<0.01; linear regression, y=−0.0018x+0.38).
n=40 intercalated discs for 38 month; Fig. 1C). Therefore, with
increasing age the spatial distributionof Cx43protein changes from
consistent expression across the disc to being present at the outer
rim only. The functional consequences of this remodelling were
ascertained as shown in Fig. 4.
In contrast to this microscopic remodelling of the Cx43 expres-
sion the macroscopic apparent distribution of Cx43 remained
unchanged with Cx43 remaining located at the cell ends with no
signs of lateralisation.
3.5. Increased age slows the conduction velocity in right atrial
muscle
For consistent assessment of the endocardial conduction veloc-
ity of the action potential propagation in the dominant direction of
spread was measured, perpendicular to the crista terminalis (CT)
(Fig. 4A). Between animals aged 1 day–1 month the conduction
velocity increased from 0.35±0.004m/s (n=5) to 0.38±0.012m/s
(n=4). However, from 1 month of age onwards over the remain-
ing lifespan the conduction velocity signiﬁcantly reduced to
0.31±0.017m/s at 38 months of age (n=6) (Fig. 4B; ANOVA
p<0.01). This atrial muscle conduction velocity signiﬁcantly neg-
atively correlated with age (linear regression, y=−0.0018x+0.38;
R2 =0.97).
3.6. Phosphorylation status changes with age
Example membranes (Fig. 5A and B) illustrates how the spe-
ciﬁc isoforms of the proteins, phosphorylated Cx43 (P-Cx43) and
activated-JNK (known also as phosphorylated JNK) increase with
progressive ageing. For each sample of right atrial muscle exam-
ined, the level of P-Cx43proteinwas expressed as a ratio of the total
Cx43 protein. The ratio of P-Cx43:total Cx43 signiﬁcantly increased
from0.48±0.02at0.03month to0.99±0.03 in theatria fromthe38
month animals (Fig. 5A;n=5;ANOVAp<0.001; y=0.0129x+0.486;
R2 =0.97). Each samplewas also assessed for levels of activated-JNK
expressed as a ratio to the non-activated JNK (NA-JNK) protein (the
non-phosphorylated isoform). The ratio of activated-JNK:NA-JNK
signiﬁcantly increased from0.14±0.01at0.03month to0.68±0.05
in the atria of the 38 month animals (Fig. 5B; n=5; ANOVA
p<0.0001; linear regression, y=0.0131x+0.1544; R2 =0.92).
Across the examined age range the levels of phosphorylated
isoforms for both proteins, Cx43 and JNK, increased. A correlation
between the increase in the level of phosphorylated P-Cx43 and
the increase in activated-JNK within the right atrial muscle was
identiﬁed (Fig. 5C; n=5 animal per age, per protein; linear regres-
sion, y=1.0305x – 0.3484; R2 =0.96). Right atrial tissue from the
old animal contained almost entirely phosphorylated Cx43 protein
(98.6±3 P-Cx43:total Cx43).
In contrast to the age-correlated increase in activated JNK
another key stress-related kinase-p38 and phosphorylated p38 did
not change signiﬁcantly between young and old, or senescent ani-
mals, and failed to show a signiﬁcant correlation with age (Fig. 5D)
suggesting the increase in JNK isnot just ageneric increase in stress-
activated MAP kinases with age.
3.7. JNK manipulation directly associates with Cx43 changes
Finallywestudied the controversial regulatory linkbetween JNK
and Cx43 using single cardiacmyocytes isolated fromhealthy adult
animals, exposed toeitherSP600125, a speciﬁc JNK inhibitor, or ani-
somycin, a speciﬁc activator of JNK, comparedwith ‘untreated’ cells
in the carrier alone (Fig. 6).Westernblot conﬁrmedexposure to ani-
somycin increased activated-JNK to 273±18%; however, SP600125
completely removed all detectable trace of activated-JNK protein
(Fig. 6A; n=10; ANOVA, p<0.01). Total Cx43 protein levels declined
in the presence of anisomycin to 41±4% and SP600125 to 2±1%.
WGA immunolabelling showed all examined myocytes had
maintained their structure. Co-localisation of Cx43 protein and
WGA,demonstrated that ‘untreated’myocytespossessedCx43pro-
tein at the intercalated discs (Fig. 6B). Exposure to anisomycin
signiﬁcantly reduced Cx43 protein at the discs to 57±7% of
untreated myocytes, compared with SP600125 which instigated a
comprehensive reduction to 11±9% of that identiﬁed in untreated
myocytes (Fig. 6B; n=20 per group; ANOVA, p<0.01).
4. Discussion
With progressive ageing there is an incrementing risk of atrial
arrhythmias to the extent that age is considered one of the main
risk factors for atrial ﬁbrillation (Siddiqi and Dickfeld, 2011). This
incrementing risk is associatedwith atrial conduction disturbances
and disruption of the normal pacemaking of the heart (Jones et al.,
2004). Conduction through themyocardium is dependent on tissue
architecture, action potential shape, size of cells and coupling con-
ductance between cells. In our previous work using this guinea-pig
model from Massons-trichrome staining we failed to identify sig-
niﬁcant ﬁbrosis/reorganisation of the atria with age in this animal
model (Jones et al., 2004) (although this is certainly a key factor
in many associated pathologies and appears to rapidly occur con-
sequent to atrial ﬁbrillation). Equally the modest hypertrophy of
cells observedwith agewould be expected to increase conductance
rather than lead to the decrease documented in this study. This
leaves action potential changes and changes in connexins as the
mainpotential problems thatpredispose to conductionproblems in
the aged atria. Age is associated with increased atrial action poten-
tial duration in several studies (for review see Dun and Boyden,
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Fig. 5. The representative membrane (A) illustrates the changes in phosphorylated Cx43 (P-Cx43) with age, expressed as the ratio of P-Cx43 to total Cx43 protein. (B)
Illustrates the changes in activated-JNK with age, expressed as a ratio of activated JNK to non-activated JNK (NA-JNK). (A–B) Desmin content is shown to verify equal protein
loading. (C) Shows the correlation between the ratio of proteins activated-JNK:NA-JNK and P-Cx43:total Cx43 across the age range (n=5 per age group; ANOVA p<0.01; linear
regression y=1.0305X–0.3484=0.96). (D) p38 (upper blot) and phosphorylated p38 (lower blot) at each age with average data shown below (mean± SD). The dashed lines
show linear regressions to the data. There is no signiﬁcant correlation between p38 or phosphorylated p38, and age (R2 = 0.03 and 0.42, respectively, by Pearson correlation).
2009) but no differences in the upstroke of the action potential,
which is key for determining propagation, have been reported and
studies on canine atrial myocytes failed to ﬁnd an age-associated
change in sodium current (Baba et al., 2006).
This leaves connexins and the associated inter-cellular con-
duction as the likely key parameter responsible for determining
changes in tissue conductivity in the atria with advancing age.
Previous reports have shown that the conduction velocity across
the right atria, although chieﬂy dependent on Cx43 expression,
also decreases if more Cx40 protein is expressed relative to Cx43
protein expression as a consequence of lower channel conduc-
tance (Kanagaratnam et al., 2002). Analysis of protein expression
with age by western blot determined that expression of Cx40 and
Cx45 proteins did not alter with age; however, a signiﬁcant pro-
gressive decrease of Cx43 protein expression levels occurred with
ageing. This decline in Cx43 expression was predicted to lead to
diminished electrical conductivity across the tissue. The associated
increased resistance to electrical communication, decreased action
potential conductionvelocity andassociated increased cardiac con-
duction times are factors purported to contribute to the generation
of arrhythmias (Kanagaratnam et al., 2002; Kistler et al., 2004).
At birth the immunoreactive Cx43 signal is uniformly dis-
tributed around the myocyte perimeter but by 1 month,
development of the heart is associated with gap junctional remod-
elling and Cx43 has relocated to the intercalated discs (Spach et al.,
2000). Despite our observation that Cx43 expression declined sig-
niﬁcantly from 1 day to 1 month, the conduction velocity of the
actionpotential in thedirectionperpendicular to the crista terminal
slightly increased from0.35±0.004m/s at 1day to0.38±0.012m/s
at 1 month of age. The spatial remodelling of the Cx43 protein
from the cellular perimeter to the intercalated disc and ensuing
improved gap junctional alignment remodelling appears to pro-
duce an anisotropic effect that accompanies an increase in the
speed of action potential conduction. Interestingly in the condi-
tion ‘Tetralogy of fallot’ this remodelling of Cx43 protein fails to
occur, and this failure has been associated with an increased risk of
arrhythmias highlighting how the distribution of Cx43 is an impor-
tant factor indetermining susceptibility to arrhythmias (Kołcz et al.,
2005).
Stress-activated MAP kinases (SAPKs) are a subset of the MAP
kinase family (MAPKs), including JNK and p38. These kinases
respond to a variety of stresses including physical, chemical,
metabolic and biological. Conditions that induce acute stress
in vivo; for example, ischemic episodes, myocardial infarction and
end-stage heart failure, are associated with increased levels of
activated-JNK and loss of Cx43 proteins (Luke and Safﬁtz, 1991;
Dupont, 2001). Exposure of cultured single cardiac myocytes to
acute stress has been shown to stimulate increased activated-JNK,
followed by down-regulation of Cx43 mRNA from 60min onwards
(Petrich et al., 2004). Post-stress Cx43 protein levels were found
to be 60% of that in untreated myocytes. The potential in vivo
consequence of this Cx43 loss is uncoupling of the functional
myocardium from injured tissue, which is thought to be protective,
electrically insulating the neighbouring myocytes and preventing
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Fig. 6. Isolated single cardiac myocytes were either treated with vehicle only (DMSO, control), exposed to the pharmacological agent SP600125 (JNK inhibitor) or anisomycin
(an activator of JNK) an example membrane from western blot (A) illustrates the associated changes in Cx43 and JNK (desmin levels verify equal protein loading). Exposure to
anisomycin increased activated-JNK (expressed as a ratio of activated-JNK to non-activated JNK) but SP600125 eliminated all trace of activated-JNK. Cx43 protein expression
signiﬁcantly declines in both the presence of anisomycin and SP600125 in comparison with the untreated myocytes (A) (n=10; ANOVA, p<0.01). The ‘untreated’ myocytes
exposed to DMSO alone show Cx43 at the intercalated discs (B) (n=20 per group). Myocytes exposed to anisomycin had signiﬁcantly less Cx43 at the intercalated discs
and SP600125 further reduced Cx43 labelling to visually undetectable levels (n=20 per group, ‡p<0.0001). The red labelling is from wheat germ agglutinin included as a
membrane marker.
extension of the infarct area (Luke and Safﬁtz, 1991). Whilst our
data is not from acutely stressed hearts, it is acknowledged that
even apparently healthy ageing can be a chronic stressor associ-
ating with induction of stress signalling pathways (Powers et al.,
2004). This inductionwith ageing is seen inourﬁnding that levels of
activated-JNK increase with age correlating directly with reduced
total Cx43. The only previous study to consider changes in JNK
activation in vivo with age used a comparison between young and
middle-aged rabbits and identiﬁed a 120% increase in JNK activa-
tion in the left atrium (Yan et al., 2013). In contrast our study across
the lifespan has shown a more than 4 fold increase in the right atria
associating directly with progressive ageing. This is not a simple
global increase in stress kinases since p38 failed to show the same
response.
Evidence of a direct link between JNK and Cx43 regulation
in the heart comes from transgenic mice with cardiac-speciﬁc
in vivo activation of JNK. These mice exhibit a phenotype of sud-
den and premature death, attributed to down-regulation of Cx43
expression, associated loss of gap junctions and slowed conduction
(Petrich et al., 2004). These ﬁndings are closely paralleled by obser-
vations from mice with a cardiac-restricted knockout of Cx43, who
at 45 days old possessed ∼20% Cx43 protein compared with their
control littermates and a signiﬁcantly slowed conduction veloc-
ity associating with an increase in their susceptibility to induced
arrhythmias (Danik et al., 2004). Similar observations have also
now been made with moderate ageing and induction of JNK in the
rabbit heart where ageing from a juvenile state to middle age as
well as anisomycin treatment both resulted in activation of JNK
and a reduction in Cx43 expression (Yan et al., 2013).
Analysis of total endogenous Cx43 protein expression in our
‘ageing’ animal model found progressive ageing reduced the Cx43
protein expressed in the right atria to 25% of the original content by
38 months correlating with a signiﬁcant increase in activated-JNK
and a reduction in action potential conduction velocity in the right
atrial muscle. A correlation previously observed within the sinoa-
trial node (Jones et al., 2004). Elderly patients suffering arrhythmic
activity have previously been observed to possess slowed conduc-
tion of the action potential associated with reduced expression of
Cx43 protein within the right atrium (Kistler et al., 2004; Kostin
et al., 2002), a ﬁnding mirrored in our animal model. Thus sim-
ilarities can be drawn between the old aged human heart, our
aged animal model and the previously discussed transgenic mouse
models: suggesting that electrical uncoupling is a result of the
diminished Cx43 expression with JNK playing a mechanistic role
in the formation of an arrhythmic substrate increasing the risk of
sudden death.
Furthermore we investigated the controversial relationship
between JNK and Cx43 expression. Anisomycin was used as an
activator of JNK (Ogawa et al., 2004; Petrich et al., 2002), which
in our hands also lead to increased phosphorylation of Cx43.
The anthrapyrazlone inhibitor of JNK, SP600125, has been pre-
viously used to inhibit JNK pathways without affecting other
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mitogen-activated protein kinase (MAPK) pathways such as p38
MAPK or extracellular signal-regulated pathways (ERK) (Bennett
et al., 2001). In our study cardiac myocytes were treated with
SP600125 and this resulted in the complete abolishment of Cx43
protein expression, an event that did not occur in the untreated
cells. This directly demonstrates the link between JNK signalling
and the regulation of Cx43 expression, but does highlight a com-
plex relationship whereby activation can cause phosphorylation
andchronicdown-regulationofCx43, similarly complete inhibition
causes a complete block of Cx43 expression. Further experiments
are required to fully understand the interactions of this linked sys-
tem.
Our data demonstrate that during healthy in vivo progressive
ageing activated-JNK accumulates as total endogenous Cx43 pro-
tein declines and phosphorylation of Cx43 protein increases in
the right atria. De-phosphorylation of Cx43 is known to lead to
reduced conductance in ischemia with potential negative and ben-
eﬁcial consequences (Beardslee et al., 2000). Phosphorylation of
Cx43 though is also known to increase Cx43 degradation (Lampe
and Lau, 2000; Popolo et al., 2013). This apparent dichotomy plays
out in the ageing heart in a manner whereby degradation increas-
ingly predominates leading to depletion of Cx43. Counter to this
the increasingly high proportion of phosphorylated Cx43 found in
the ageing heart could therefore be considered as maximising con-
ductance from the decreasing number of gap junctions expressed,
a change which ultimately fails to maintain homeostasis due to the
elevated degradation. Future work will be able to evaluate further
the changes in protein turn-over with ageing and the role the acti-
vation of JNK plays in altering this. On the current data though it
would appear the elevating activation of JNK with age is serving
to drive the atria into a pro-arrhythmic state by ultimately induc-
ing loss of Cx43 accompanying functional remodelling and reduced
conduction.
5. Conclusions
We have provided novel evidence that JNK signalling is a medi-
ator of gap junctional remodelling during progressive ageing of the
right atria by a mechanism that could account for the observed
dynamic changes in Cx43 protein expression. JNK activation can
explain changes in conduction and associated connexin remod-
elling in the aged heart, providing an important link between the
progressing chronic stress of ageing and increasing susceptibil-
ity to arrhythmias. Identiﬁcation of the role of JNK in the aged
heart requires further investigation to determine if it is a ther-
apeutic target worth pursuing in elderly patients at risk from
atrial arrhythmias. With an appropriately directed cardiac-speciﬁc
pharmacological tool, the attenuation of activated-JNK could off-
set the age-dependent effects. Although not pharmacological, one
intervention already known to attenuate the JNK stress-induced
cell signalling mechanism providing protection to young and old
hearts against stress-relateddamage is exercise (Boluyt et al., 2003;
Kumar and Tatu, 2003; Powers et al., 2004). Thus, our data provides
evidence how in vivo ageing manipulates the expression of Cx43
protein in the heart by the JNK pathway resulting in slowed cardiac
action potential conduction and an increased risk of arrhythmias
in the ageing population.
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